LAUREN WINDSOR: Open Payments
NPI 1841762739 · BESSEMER, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,152 in 46 payments from 13 companies in 2025. Trend: 2023 $536 · 2024 $696 · 2025 $1,152
Food & beverage: $1,152
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $292 |
| Novartis Pharmaceuticals Corporation | 10 | $233 |
| AstraZeneca Pharmaceuticals LP | 6 | $190 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $89 |
| PFIZER INC. | 3 | $61 |
| Alnylam Pharmaceuticals Inc. | 3 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $54 |
| Baxter Healthcare | 2 | $37 |
| GENZYME CORPORATION | 1 | $32 |
| BridgeBio Pharma, Inc. | 2 | $32 |
Products named: Wegovy, LEQVIO, LOKELMA, Kerendia, AMVUTTRA, JARDIANCE, VYNDAQEL, FABRAZYME.
Industry payments across AL — which companies pay providers there.
